PRTA Earnings

PRTA reported its FY2025Q3 earnings on 2025-11-06, showcasing a revenue of 2.42M against an estimate of 6.64M, resulting in a -63.62% surprise. The EPS was -0.67, surpassing the expected -0.6 by -11.67%. The stock experienced a 4.76% price change on the earnings day and a 7.64% change over the next five days, reflecting market reactions to the results.

Following PRTA's FY2025Q3 earnings announcement on 2025-11-06, the stock price moved by 4.76% on the day of the release. Over the subsequent five days, it saw a 7.64% change. Historically, PRTA's stock price tends to shift by an average of 3.4% in the 10 days leading up to earnings and 0.66% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate PRTA's annual revenue to reach 76.67M, while the EPS is projected at -0.33. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between PRTA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, PRTA's stock price typically moves by 3.4% in the 10 days before its earnings and 0.66% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of -0.33 and revenue of 76.67M.

The earnings call reflects a mixed sentiment. Financial performance shows prudent capital utilization but also a significant net loss. The Q&A highlights promising developments in product trials and partnerships, but also reveals management's reluctance to provide detailed guidance, creating uncertainty. The share redemption plan indicates potential shareholder value but lacks immediate impact. Overall, the stock is likely to remain neutral, with no strong catalysts for significant movement. The market cap suggests moderate sensitivity to these factors.